Hosted on MSN1mon
Pfizer director Ronald E. Blaylock acquires $499,072 in stockOn February 13, Ronald E. Blaylock, a director at Pfizer Inc. (NYSE:PFE), purchased 19,457 shares of the company's common stock. The transaction was valued at a total of $499,072, with each share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback